More MS news articles for March 2001

Teva Neuroscience and Spotlight Health Launch Multiple Sclerosis Public Awareness Campaign

Integrated Media Campaign to Raise Awareness About Multiple Sclerosis and Treatment Options

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-12-2001/0001445356&EDATE=

LOS ANGELES, March 12 /PRNewswire/ -- Teva Neuroscience and Spotlight Health today launched a strategic relationship to educate the general public about Multiple Sclerosis and the treatment and support options available to those suffering from this potentially debilitating disease.

Multiple Sclerosis is a disorder of the central nervous system (brain and spinal cord) involving decreased nerve function associated with the formation of scars on the covering of nerve cells.  There are 250,000 reported cases of multiple sclerosis in the United States alone, according to the National Multiple Sclerosis Society.  But it is estimated that the actual number of Americans with MS may be closer to one half million because many people with mild symptoms never seek medical attention.

Mild symptoms often include vision or dexterity problems, numbness or tingling sensations.  In some patients, more severe symptoms may eventually include a partial or complete loss of vision or mobility.  Being aware of the symptoms and when and how to seek medical attention is paramount to the early diagnosis and treatment of MS and therefore an important component of the relationship between Teva Neuroscience and Spotlight Health.

"Teva Neuroscience has been and continues to be committed to the management of multiple sclerosis through our products and services," said Larry Downey, CEO of Teva Neuroscience.  "By partnering with Spotlight Health we will be able to increase both the access and modes of disseminating detailed information about the disease as well as offer additional methods of support for both the patient and their carepartners."

"Spotlight Health's goal is to focus on specific health issues, raise awareness and help consumers make informed decisions about their health," said Richard Hull, President and CEO of Spotlight Health.  "Our relationship with Teva Neuroscience allows us to increase the amount of information available to our consumers and continue in our goal to be the most effective provider of health-issue communication campaigns."

The omnimedia campaign created by Spotlight Health will include print materials, educational videos, support tools and live events with medical experts.  In addition, Spotlight Health's Web site http://www.spotlighthealth.com will include interactive live chats, support groups, and other tools designed to educate consumers about MS.

About Teva Neuroscience:

Teva Neuroscience is a division of Teva Pharmaceutical Industries, Ltd. Teva Neuroscience is dedicated to the investigation and development of innovative products and services that address the health management needs of people with multiple sclerosis.

About Spotlight Health:

Spotlight Health is the leading creator of celebrity-featured omni-media health care content and communication programs.  With the guidance of the world's top medical experts, compelling stories of celebrities' personal health experiences are merged with accurate, understandable medical information -- creating content that combines the magnetic attraction of celebrity with the assurance of medical authority.  Spotlight Health delivers this content to both consumers and physicians through multiple, coordinated, distribution channels -- including web, television, radio, print, software, and live events.

SOURCE Spotlight Health
Web Site: http://www.spotlighthealth.com